Waters Corp. (WAT) Tops Q2 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Waters Corp. (WAT) PT, Estimates Raised at Jefferies Post Q2
July 23, 2014 9:00 AM EDTJefferies analyst Brandon Couillard raised his price target on Waters Corp. (NYSE: WAT) to $105.00 (from $98.00) following Q2 results but maintained a Hold rating.
Couillard comments, "Post WAT's 2Q14 print, we are raising our 2014 & 2015 EPS forecasts to $5.32 (from $5.30) and $5.82 (from $5.80), respectively, which imply... More
Waters Corp. (WAT) Acquires MediMass' REIMS Technology
July 22, 2014 9:48 AM EDTWaters Corp. (NYSE: WAT) announced the acquisition of Rapid Evaporative Ionization Mass Spectrometry (REIMS) technology from MediMass Ltd. The REIMS technology represents substantially all of the assets of MediMass and includes patent applications, software, databases and REIMS expertise.
While showing promise across many applications, REIMS technology significantly strengthens Waters technology position within Health Sciences, said Rohit Khanna, Vice-President, Worldwide Marketing and Informatics, Waters Division. This technology acquisition along with our... More
